About this trial
The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
POSEIDON group 3 and 4
GnRH antagonist IVF cycle
Disqualifiers
Hypogonadotrophic hypogonadism
Endometriosis
History of recurrent abortion
Trial design
Parallel
Treatments tested in this trial
Double trigger
DrugTriptorelin (0.2 mg/S.C ) and HCG (10000 IU/I.M) are administered 38 to 39 h and 35 to 36 h prior to ovum pick-up., respectively.
HCG trigger
DrugHCG (10000 IU/I.M) is administered 35 to 36 h prior to ovum pick-up.
Treatment groups
Trial outcomes
Primary outcomes
Metaphase-II oocytes rate
Number of MII oocyte/ number of cumulus oocyte complex
Secondary outcomes
Clinical pregnancy rate
Presence of intrauterine gestational sac detected by transvaginal ultrasound
Ongoing pregnancy Rate
Pregnancies continued beyond 20 weeks gestation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: